Please login to the form below
Donanemab
This page shows the latest Donanemab news and features for those working in and with pharma, biotech and healthcare.
Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes
Drug demonstrated a 'significant' slowing of cognitive decline. Eli Lilly’s amyloid-targeting antibody donanemab has shown promise in the treatment of Alzheimer’s disease, sending its stocks soaring and renewing ... function’. In other measures,
Latest news
-
Germany’s Vivoryon raises €43m for Alzheimer’s drug trial
Eli Lilly is developing an antibody drug against it – called donanemab – which has reached the phase 2 testing stage.
-
Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
Its pipeline currently includes solanezumab for Alzheimer’s – which has already failed earlier phase 3 trials – along with two antibodies for the disease in mid-stage testing (donanemab and zagotenemab) and
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- New study identifies drugs that are safe to use in COVID-19 treatment
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
